Nitrosative stress in Parkinson's disease.
Morgan G Stykel1, Scott D Ryan2,3
1The Department of Molecular and Cellular Biology, The University of Guelph, Guelph, ON N1G 2W1, ON, Canada.
NPJ Parkinson'S Disease
|August 11, 2022
Summary
Reactive nitrogen species (RNS) contribute to the loss of dopaminergic neurons in Parkinson's Disease (PD). Targeting RNS, particularly through S-nitrosylation, shows therapeutic promise for early-stage PD patients.
Area of Science:
- Neuroscience
- Biochemistry
- Pathology
Background:
- Parkinson's Disease (PD) involves dopaminergic neuron loss in the nigral-striatal pathway.
- Reactive nitrogen species (RNS), including nitric oxide (NO), are implicated in this neurodegeneration.
Purpose of the Study:
- To review the mechanisms by which RNS contribute to dopaminergic neuron loss in PD.
- To investigate RNS accumulation as a central signaling event in PD pathogenesis.
- To explore therapeutic strategies targeting RNS.
Main Methods:
- Review of cellular sources of RNS in PD (nNOS, iNOS, nitrate/nitrite reduction).
- Analysis of RNS-induced protein post-translational modifications, specifically S-nitrosylation.
- Examination of RNS impact on alpha-synuclein (aSyn) and PD-related cellular dysfunctions.
Main Results:
- RNS sources are upregulated in PD, leading to RNS accumulation.
- Over one-third of Lewy Body proteins are S-nitrosylated, causing deleterious neuronal effects.
- Nitration of alpha-synuclein (aSyn) promotes misfolding and toxicity; RNS modulates axo-dendritic, mitochondrial, and dopamine dysfunctions.
Conclusions:
- RNS accumulation is a key factor in PD neurodegeneration.
- Targeting RNS, specifically protein S-nitrosylation, demonstrates therapeutic potential in clinical trials for early PD.
More Related Videos
Related Concept Videos
Parkinson's Disease: Treatment
363
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
363
Parkinson's Disease: Overview
686
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
686
Drugs Affecting Neurotransmitter Synthesis
1.5K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.5K
Neural Regulation
39.7K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.7K
2° Amines to N-Nitrosamines: Reaction with NaNO2
4.5K
Secondary amines react with nitrous acid to form N-nitrosamines, as depicted in Figure 1. Nitrous acid, a weak and unstable acid, is formed in situ from an aqueous solution of sodium nitrite and strong acids, such as hydrochloric acid or sulfuric acid, in cold conditions. In the presence of an acid, the nitrous acid gets protonated. The subsequent loss of water results in the formation of the electrophile known as nitrosonium ion.
4.5K
Antihypertensive Drugs: Vasodilators
625
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
625


